TMEM102
Transmembrane protein 102
Also known as: CBAP, FLJ36878, TM102_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8N9M5
- Gene
- TMEM102
- Ensembl
- ENSG00000181284
- Chromosome
- 17
- Canonical length
- 508 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Vesicles
OverviewNCBI Gene
Involved in regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway; response to cytokine; and signal transduction. Acts upstream of or within positive regulation of T cell migration and positive regulation of cell adhesion. Located in cell surface. Part of protein-containing complex. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
508 residues, UniProt reviewed canonical sequence.
>Q8N9M5|TMEM102
1 MASAVWGSAP WWGPPPPAPA RPLTDIDFCS GAQLQELTQL IQELGVQESW SDGPKPGADL
61 LRAKDFVFSL LGLVHRRDPR FPPQAELLLL RGGIREGSLD LGHAPLGPYA RGPHYDAGFT
121 LLVPMFSLDG TELQLDLESC YAQVCLPEMV CGTPIREMWQ DCLGPPVPGA RDSIHRTESE
181 ESSKDWQSSV DQPHSYVTEH EAPVSLEKSP SDVSASESPQ HDVVDLGSTA PLKTMSSDVT
241 KAAVESPVPK PSEAREAWPT LCSAQVAAWF FATLAAVAES LIPVPGAPRL VHAARHAGFT
301 TVLLATPEPP RRLLLFDLIP VVSVAGWPEG ARSHSWAGPL ASESASFYLV PGGGTERPCA
361 SAWQLCFARQ ELALKARIPA PLLQAHAAAQ ALLRPLVAGT RAAAPYLLRT LLYWACERLP
421 ALYLARPENA GACCLGLLDE LGRVLEAGTL PHYFLNGRQL RTGDDSAALL GELARLRGDP
481 ARALRAAVEE AKVARKGGGL AGVGGGAHLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TMEM102 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.36
- Highest tissue expression
- 9.8 nTPM
Expression across tissuesHPA
Tissue
- esophagus: 9.8 nTPM
- skin: 8.5 nTPM
- adrenal gland: 8.1 nTPM
- testis: 6.4 nTPM
- spleen: 6.1 nTPM
- salivary gland: 5.9 nTPM
Single-cell type
- paneth cells: 3.9 nCPM
- papillary tip epithelial cells: 3.3 nCPM
- renal collecting duct principal cells: 2.4 nCPM
- loop of henle epithelial cells: 1.7 nCPM
- late spermatids: 1.5 nCPM
- podocytes: 1.5 nCPM
Immune cell
- eosinophil: 3.9 nTPM
- NK-cell: 1 nTPM
- non-classical monocyte: 1 nTPM
- intermediate monocyte: 0.9 nTPM
- memory CD8 T-cell: 0.9 nTPM
- memory B-cell: 0.8 nTPM
Brain region
- cerebellum: 2 nTPM
- medulla oblongata: 2 nTPM
- pons: 1.8 nTPM
- thalamus: 1.8 nTPM
- basal ganglia: 1.7 nTPM
- midbrain: 1.7 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.12
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.92
- DepMap mean gene effect
- -0.11
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- apoptotic process
- positive regulation of cell adhesion
- positive regulation of T cell chemotaxis
- positive regulation of T cell migration
- regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway
- response to cytokine
- signal transduction
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TMEM102 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TMEM102 as an antibody target. Whether an autoantibody or antibody against TMEM102 could matter depends on whether native TMEM102 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TMEM102 is annotated at the cell surface, where native TMEM102 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label TMEM102 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...